Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LAMB2 |
| Upstream (Parents) |
|---|
| (<<) AKT3 → LAMB2 |
| (<<) CAV1 → LAMB2 |
| (<<) CLDN5 → LAMB2 |
| (<<) EFEMP2 → LAMB2 |
| (<<) FZD4 → LAMB2 |
| (<<) GNG11 → LAMB2 |
| (<<) IGFBP4 → LAMB2 |
| (<<) IL1R1 → LAMB2 |
| (<<) MSN → LAMB2 |
| (<<) MXRA8 → LAMB2 |
| (<<) PTRF → LAMB2 |
| (<<) SYNPO → LAMB2 |
| (<<) TCF4 → LAMB2 |
| (<<) TIMP3 → LAMB2 |
| Downstream (Children) |
|---|
| LAMB2 → BMP1 (>>) |
| LAMB2 → CASP10 (>>) |
| LAMB2 → CRTC1 (>>) |
| LAMB2 → DUSP2 (>>) |
| LAMB2 → EMG1 (>>) |
| LAMB2 → EPHB6 (>>) |
| LAMB2 → FDPS (>>) |
| LAMB2 → GAL (>>) |
| LAMB2 → JAK1 (>>) |
| LAMB2 → KLHL7 (>>) |
| LAMB2 → MAP3K12 (>>) |
| LAMB2 → MAP3K3 (>>) |
| LAMB2 → MYLK (>>) |
| LAMB2 → PAK6 (>>) |
| LAMB2 → PLD3 (>>) |
| LAMB2 → RHOB (>>) |
| LAMB2 → SHFM1 (>>) |
| LAMB2 → TK2 (>>) |
